EXICURE, INC. Accrued Liabilities, Current
EXICURE, INC. (XCUR) had Accrued Liabilities, Current of $1.99 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $1.99M.
- 2026-03-31: Accrued Liabilities, Current $2.02M.
- 2025-12-31: Accrued Liabilities, Current $2.20M.
- 2025-09-30: Accrued Liabilities, Current $1.46M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.99M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.02M 10-Q · filed 2026-05-29 | |
| 2025-12-31 | $2.20M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.46M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.73M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $2.68M 10-Q · filed 2025-06-27 | |
| 2024-12-31 | $2.04M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $2.32M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $846.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $836.00K 10-Q · filed 2024-06-17 | |
| 2023-12-31 | $879.00K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $1.36M 10-Q · filed 2024-05-16 | |
| 2023-06-30 | $1.09M 10-Q/A · filed 2024-06-06 | |
| 2023-03-31 | $1.48M 10-Q/A · filed 2024-06-06 | |
| 2022-12-31 | $1.28M 10-Q/A · filed 2024-06-06 | |
| 2022-09-30 | $3.02M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.31M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $3.23M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $6.46M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $5.48M 10-Q · filed 2021-11-19 | |
| 2021-06-30 | $3.23M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.44M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $3.52M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $2.12M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.95M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.27M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $2.44M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $2.24M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.78M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.59M 10-Q · filed 2019-05-08 | |
| 2019-01-01 | $1.79M 10-K · filed 2020-03-10 | |
| 2018-12-31 | $1.54M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $3.04M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.65M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.26M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.27M 10-K/A · filed 2019-09-23 | $1.37M 10-K · filed 2018-03-09 |
| 2017-09-30 | $2.50M 10-Q · filed 2017-11-14 | |
| 2016-12-31 | $2.16M 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |